European Parliament committee unanimously supports tighter measures for breast implants
This article was originally published in Clinica
Executive Summary
The pressure is on for Europe to go one step further in tightening requirements for silicone gel breast implants. Members of the European Parliament's Committee on the Environment, Public Health and Consumer Policy (ENVI) unanimously adopted on January 22 a report that demands measures for breast implants that go beyond those proposed by the European Commission in the context of its non-legislative Communication.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.